U.S. Food and Drug Administration Updates CAMZYOS ® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications

1. Homepage
2. Finance
3. U.S. Food and Drug Administration Updates CAMZYOS ® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications